Clincosm LogoSign in Get a demo

advanced ovarian cancer

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

Not yet recruiting
  • Serous Ovarian Cancer
  • Advanced Ovarian Cancer
  • (no location specified)
Sep 20, 2023

Advanced Ovarian Cancer Trial in Guangzhou (Plasmodium immunotherapy)

Not yet recruiting
  • Advanced Ovarian Cancer
  • Plasmodium immunotherapy
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Southern Medical University
Jul 5, 2023

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt

Not yet recruiting
  • Advanced Ovarian Cancer
  • None (Observational Study)
  • (no location specified)
Mar 8, 2023

Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

Completed
  • Advanced Ovarian Cancer
  • Sabadell, Barcelona, Spain
  • +7 more
Jan 25, 2023

Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom

Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +3 more
Dec 19, 2022

Advanced Ovarian Cancer Trial in Shanghai (Tranexamic Acid, normal saline)

Completed
  • Advanced Ovarian Cancer
  • Tranexamic Acid
  • normal saline
  • Shanghai, Shanghai, China
    Shanghai Cancer Center, Fudan University
May 30, 2022

Advanced Ovarian Cancer Trial in Fujian (SC10914)

Unknown status
  • Advanced Ovarian Cancer
  • Fujian, China
    Fujian Cancer Hospital
May 11, 2021

Advanced Ovarian Cancer Trial in Barcelona, Valencia (Multimodal Prehabilitation)

Recruiting
  • Advanced Ovarian Cancer
  • Multimodal Prehabilitation
  • Barcelona, Spain
  • +1 more
Apr 24, 2021

Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer Trial run by the NCI (BMN 673)

Completed
Has Results
  • Advanced Ovarian Cancer
  • +3 more
  • BMN 673
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 2, 2021

Advanced Ovarian Cancer, Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab, RO6870810)

Terminated
  • Advanced Ovarian Cancer
  • Triple Negative Breast Cancer
  • Boston, Massachusetts
  • +10 more
Nov 5, 2020

Advanced Ovarian Cancer, Malignant Melanoma Trial in Toronto (drug, procedure, biological)

Completed
  • Advanced Ovarian Cancer
  • Malignant Melanoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Aug 12, 2020

Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as

Completed
  • Advanced Ovarian Cancer
  • Intraperitoneal chemotherapy
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Jun 25, 2020

Advanced Ovarian Cancer Trial (Bevacizumab)

Not yet recruiting
  • Advanced Ovarian Cancer
  • (no location specified)
Jul 26, 2018

Advanced Ovarian Cancer Trial in Seoul (Neoadjuvant chemo, Carboplatin)

Completed
  • Advanced Ovarian Cancer
  • Seoul, Korea, Republic of
    Asan Medical Center
May 27, 2017

Advanced Solid Malignant Tumors, Advanced Ovarian Cancer Trial in United States (U3-1565)

Completed
  • Advanced Solid Malignant Tumors
  • Advanced Ovarian Cancer
  • Detroit, Michigan
  • +3 more
May 16, 2014